Case Nos: CA-2024-002655/002675/002676 - [2025] EWCA Civ 936

The Patent

The judge summarised the disclosure of the Patent at [385]-[405], and considered a dispute as to whether Figure 21 showed that RD162' was more effective than RD162 at [406]-[418], but for the purposes of the appeal it is sufficient to note that Claim 1 is to RD162' or a pharmaceutically acceptable salt thereof.